(Q36905622)

17 August 2017

1 reference

title

Inhalation toxicology of ricin preparations: animal models, prophylactic and therapeutic approaches to protection (English)

1 reference

17 August 2017

Gareth D Griffiths

1

1 reference

17 August 2017

Gary J Phillips

series ordinal

2

1 reference

17 August 2017

Jane Holley

series ordinal

3

1 reference

17 August 2017

publication date

1 August 2007

1 reference

17 August 2017

published in

Inhalation Toxicology

1 reference

17 August 2017

volume

19

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

873-887

1 reference

Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

21 January 2018

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Monovalent and polyvalent carbohydrate inhibitors of ricin binding to a model of the cell-surface receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

The distribution of [125I]ricin in mice following aerosol inhalation exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

The use of anti-ricin antibodies to protect mice intoxicated with ricin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

A novel neutralizing monoclonal antibody against cell-binding polypeptide of ricin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

An improved constant output atomizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Purification and physicochemical properties of ricins and agglutinins from Ricinus communis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Insertional mutagenesis of ricin A chain: a novel route to an anti-ricin vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

The interaction of Ricinus communis agglutinin with normal and tumor cell surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Finding a new vaccine in the ricin protein fold

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Therapy and prophylaxis of inhaled biological toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Crystallographic refinement of ricin to 2.5 A

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

A novel recombinant vaccine which protects mice against ricin intoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Ribosome-inactivating proteins: progress and problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Ribosome-inactivating proteins up to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

Ribosome-inactivating proteins from plants: present status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

A pilot clinical trial of a recombinant ricin vaccine in normal humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

A novel designed single domain antibody on 3-D structure of ricin A chain remarkably blocked ricin-induced cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08958370701432124

10.1080/08958370701432124

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference